For many adults, especially over 40, this anti-aging duo could offer sustainable support against the biological wear and tear that drives both visible and invisible signs of aging, such as skin changes, a slower metabolism, stubborn fat, brain fog, fatigue, and slower recovery
Combination peptide therapy (e.g., GLP-1 agonists with other metabolic agents) may become better in the future as research evolves
Neither conclusion can be applied to humans at typical compounded doses (250 to 500 mcg subcutaneously) because: Rodent doses (10 mcg/kg intraperitoneally) do not translate linearly to human subcutaneous pharmacokinetics
This is a complicated, expensive, and time-consuming process, which drives up retail prices
When its done by a trained professional, youll absorb it better, see results faster, and avoid unnecessary side effects
Supervised care is not a marketing claim